Advances in the interaction of lipoxin A4 and its analogues with macrophages to promote the abatement of inflammatory responses
DOI:
CSTR:
Author:
Affiliation:

The First Affiliated Hospital of Nanjing Medical University

Clc Number:

Fund Project:

The National Natural Science Foundation of China (General Program, Key Program, Major Research Plan)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Lipoxin A4 (LXA4) is a natural pro-catabolic molecule produced by endogenous fatty acids that is known as the "brake signal" of inflammatory factors. It has a powerful anti-inflammatory effect, but its metabolism is fast, and LXA4 analogues are relatively more stable and also have certain anti-inflammatory effects. The star cell in the fight against inflammation, the macrophage, is a vital component of our natural immunological barrier and plays a crucial role in inflammation reduction, as does LXA4. LXA4 and its analogs are intricately related to macrophages in the anti-inflammatory process. The interactions between the two in the inflammatory response are examined in order to generate novel ideas for treating a variety of inflammation-related disorders.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:October 11,2023
  • Revised:December 05,2023
  • Adopted:April 03,2024
  • Online:
  • Published:
Article QR Code